Page last updated: 2024-08-24

plerixafor and Hemophilia A

plerixafor has been researched along with Hemophilia A in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, CL; Lyle, MJ; Miao, CH; Shin, SC	1

Other Studies

1 other study(ies) available for plerixafor and Hemophilia A

Article	Year
Strategies to target long-lived plasma cells for treating hemophilia A inhibitors. Cellular immunology, 2016, Volume: 301 Topics: Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Benzylamines; Cyclams; Disease Models, Animal; Enzyme-Linked Immunospot Assay; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hemophilia A; Heterocyclic Compounds; Immune Tolerance; Immunosuppressive Agents; Mice; Plasma Cells; Receptors, CXCR4	2016

Article

Year

Strategies to target long-lived plasma cells for treating hemophilia A inhibitors.

Cellular immunology, 2016, Volume: 301

Topics: Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Benzylamines; Cyclams; Disease Models, Animal; Enzyme-Linked Immunospot Assay; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hemophilia A; Heterocyclic Compounds; Immune Tolerance; Immunosuppressive Agents; Mice; Plasma Cells; Receptors, CXCR4

2016